A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel Arm, Multicenter Study Evaluating the Efficacy and Safety of Pridopidine in Patients with Early Stage of Huntington Disease

10394PL101-HD301Open (affiliates only)A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel Arm, Multicenter Study Evaluating the Efficacy and Safety of Pridopidine in Patients with Early Stage of Huntington DiseaseNCT04556656IndustrialAdultTreatmentIIIOtherAnderson, KarenGeorgetown University Medical Center; Lombardi Comprehensive Cancer CenterGUMC Huntington Disease Care Ed & Rsch Center; GUMC PFS; GUMC Psychiatry2026.1.0 Build 16 <a href="https://advarra.com" target="_blank">© 2026 Advarra, Inc.</a>